Article information
Full text is only aviable in PDF
Bibliografía
[1.]
A. Szentivanyi.
The beta adrenergic theory of the atopic abnormality in bronchial asthma.
J Allergy, 42 (1968), pp. 203-232
[2.]
P.J. Barnes.
Neural control of human airways in health and disease.
Am Rev Respir Dis, 134 (1986), pp. 1.289-1.314
[3.]
H. Dale.
On some physiological actions of Ergot.
Physiol, 34 (1906), pp. 163-206
[5.]
A. Lands, A. Arnold, J. McAuliff.
Differentiation of receptors Systems activated by sympathomimetic amines.
Nature, 214 (1967), pp. 597-598
[6.]
S.G. Farmer.
Bradykinin-induced airway microvascular leakage and bronchoconstriction are mediated via a bradykinin beta-2 receptor.
Am Rev Respir Dis, 144 (1991), pp. 237-238
[7.]
R.G. Goldie.
Receptors in asthmatic airways.
Am Rev Respir Dis, 141 (1990), pp. sl51-sl56
[8.]
H.J. Motulsky, P.A. Insel.
Adrenergic receptors in man.
N Engl J Med, 307 (1982), pp. 18-24
[9.]
G.A. Robinson, R.W. Buycher, E.W. Sutherland.
Adenylcyclase as an adrenergic receptor.
Ann N Y Acad Sci, 139 (1967), pp. 703-707
[10.]
H.B. Bournf, K.L. Melmon.
Adenyl cyclase in human leukocytes evidence for activation by separate beta adrenergic and prostaglandin receptors.
J Pharmacol, 178 (1971), pp. 1
[11.]
G.A. Robinson, R.W. Butcher, E.W. Sutherland.
Cyclic AMP.
Academic Press, (1971),
[12.]
R.J. Lefkowitz, M.G. Caron, G.L. Stiles.
Mechanisms of membrane-receptor regulation. Biochemical, physiological and clinical insights derived from studies of the adrenergic receptors.
N Engl J Med, 310 (1984), pp. 1.570-1.579
[13.]
R.J. Lefkowitz.
Direct binding studies of adrenergic receptors: Biochemical, physiologic and clinical implications.
Ann Int Med, 91 (1979), pp. 450-458
[14.]
J.A. Beavo, N.L. Rogers, D.B. Crofford, et al.
Effects of phosphodiesterase inhibitors on cyclic AMP levels and on lipolysis.
Ann N Y Acad Sci, 185 (1971), pp. 129
[15.]
C.M. Frase, J.C. Venter.
Beta-adrenergic receptors: relationship of a primary structure. receptor function an regulation.
Am Rev Respir Dis, 141 (1990), pp. S22-S30
[16.]
D.R. Sibley, J.L. Benovic, M.G. Caron, R.J. Lefkowitz.
Regulation of transmembrane signaling by receptor phosphorilation.
Cell, 48 (1987), pp. 913-922
[17.]
J.L. Diez Jarilla, J. González Macias, M. Martín Rodríguez, J.A. García Talavera, S. De Castro Del Pozo.
El sistema de la adenil ciclasa en pacientes asmáticos (I). Excreción urinaria de AMPc tras la administración de un agonista beta-2 adrenérgico.
Med Clin, 81 (1983), pp. 468-471
[18.]
P.J. Barnes, J.S. Kalimer, C.T. Dollery.
Human lung adrenoceptors studied by radioligand binding.
Clin Sci, 58 (1980), pp. 457-461
[19.]
J.R. Carstairs, A.J. Nimmo, P.J. Barnes.
Autoradiographic visualization of beta-adrenoceptor. Subtypes in human lung.
Am Rev Respir Dis, 132 (1985), pp. 541-547
[20.]
R.J. Phipps, I.P. Williams, P.S. Richardson, J. Pell, R.J. Pack, N. Weight.
Simpathetic drug stimulate the oputput of secretory glycoprotein from human bronchi in vitro.
Clin Sci, 63 (1982), pp. 23-28
[21.]
P.J. Barnes, C.B. Basbaum, J.A. Nadel, J.M. Roberts.
Localizaron of beta-adrenoceptors in mammalian lung by light microscopic autoradiography.
Nature, 299 (1982), pp. 444-447
[22.]
J.R. Carstairs, A.J. Nimmo, P.J. Barnes.
Autoradiographic localization of beta-adrenoceptors in human lung.
Eur J Pharmacol, 103 (1984), pp. 189-190
[23.]
C. Davis, M.S. Kannan, T.R. Janes, E.E. Daniel.
Control of human airway smooth muscle in vitro studies.
J Appl Physiol, 53 (1982), pp. 1.080-1.087
[24.]
P.R. Butchers, I.F. Skidmore, C.J. Varchey, A.M. Wheeldon.
Characterization of the receptor mediating the anti-anaphylatic effects of beta-adrenoceptor agonist in human lung tissue in vitro.
Br J Pharmacol, 71 (1980), pp. 663-667
[25.]
J.M. Hughes, J.P. Seale, D.M. Temple.
Effect of fenoterol on immunological release of leukotrienes and histamine from human lung in vitro: selective antagonism by beta adrenoceptor antagonists.
Eur J Pharmacol, 95 (1983), pp. 239-245
[26.]
O.E. Brodde, G. Engel, D. Meyer, K.D. Bock, F. Weber.
The beta-adrenergic receptor in human lymphocytes: subclassification by the use of a new radioligand, 125Iodocyanopindolol.
Life Sci, 29 (1981), pp. 2.189-2.198
[27.]
S.P. Galant, S. Underwood, L. Duriseti, P.A. Insel.
Characterization of high-affinity beta-2 adrenergic receptor binding of 3Hdihydroalprenolol to human polymorphonuclear cell particulates.
J Lab Clin Med, 92 (1978), pp. 613-618
[28.]
R.D. Aarons, A.S. Nies, J. Gal, L.R. Hegstrand, P.B. Molinoff.
Elevation of beta adrenergic receptor density in human lymphocytes after propanolol administration.
J Clin Invest, 65 (1980), pp. 949-957
[29.]
L.T. Williams, R. Snyderman, R.J. Lefkowitz.
Identification of beta adrenergic receptors in human lymphocytes by 3H alprenolol binding.
J Clin Invest, 57 (1976), pp. 149-155
[30.]
E. Haen.
The peripheral lymphocyte as clinical model for receptor disturbances asthmatic disease.
Bull Eur Physiopathol Respir, 23 (1987), pp. 539-541
[31.]
S.R. Najorski, D.B. Barnett.
Biochemical assessment of adrenoceptor function and regulation: new directions and clinical relevance.
Clin Sci, 63 (1982), pp. 97-105
[32.]
J.F. Tohmen, P.E. Cryer.
Biphasic adrenergic modulation of beta adrenergic receptors in man.
J Clin Invest, 64 (1980), pp. 836-840
[33.]
J. Fraser, J. Nadeau, D. Robertson, A.J.J. Wood.
Regulation of human leukocyte beta adrenergic receptors by endogenous catecholamines.
J Clin Invest, 67 (1981), pp. 1.777-1.784
[34.]
S.P. Galant, L. Duriseti, S. Underwood, P.A. Insel.
Decreased beta adrenergic receptors in polymorphonuclear leukocytes after adrenergic therapy.
N Engl J Med, 299 (1978), pp. 933-936
[35.]
S. Holgate, C.J. Baldwin, A.E. Tattersfield.
Beta adrenergic agonist resistance in normal human airways.
Lancet, 2 (1977), pp. 375-377
[36.]
A. Kalisker, H.E. Nelson, J.E. Middleton.
Drug induced changes of adenylate cyclase in cells from asthmatic and non asthmatic subjects.
J Allergy Clin Immunol, 60 (1977), pp. 259-265
[37.]
P.L.B. Bruynzeel.
Changes in the beta-adrenergic System due to beta-adrenergic therapy: clinical consequences.
Eur J Respir Suppl, 135P (1984), pp. 62-71
[38.]
M. Middeke, J. Remien, M. Holzgreve.
The influence of sex, age, blood pressure and physical stress on beta-2 adrenoceptor density of mononuclear cells.
J Hypertension, 2 (1984), pp. 261-264
[39.]
A. De Blasi, A.S. Maisel, A.D. Feldman, et al.
In vivo regulation of beta adrenergic receptors on human mononuclear leukocytes: Assessment of receptor number, location and function after posture change, exercise and isoproterenol infusion.
J Clin Endocrinol Metab, 63 (1986), pp. 847-853
[40.]
T.K. Harden, C.U. Cotton, G.L. Waldo, J.K. Lutton, J.P. Perkins.
Catecholamine-induced alteration in the sedimentation behavior of membrane bound beta adrenergic receptors.
Science, 210 (1980), pp. 441-443
[41.]
J.R. Hadcock, C.C. Malbon.
Down regulation of beta adrenergic receptors: agonist-induced reduction in receptor mRNA levels.
Proc Nati Acad Sci USA, 85 (1988), pp. 5.021-5.025
[42.]
C.M. Fraser, J.C. Venter.
The synthesis of beta adrenergic receptors in cultured human lung cells: induction by glucocorticoids.
Biochem Biophys Res Commun, 94 (1980), pp. 390-397
[43.]
K. Mano, A. Akbarzadeh, R.G. Townley.
Effect of hydrocortisone on beta adrenergic receptors in lung membranes.
Life Sci, 25 (1979), pp. 1.930
[44.]
S. Collins, M.G. Carón, R.J. Lefkowitz.
Beta-2 adrenergic receptors in hámster smooth muscle cells are transcriptionally regulated by glucocorticoids.
J Biol Chem, 263 (1988), pp. 9.067-9.070
[45.]
Szentivanyi A, Polson JB, Szentivanyi J. Regulación adrenérgica. En: Weiss, E.B., Segal, M.S., Stein, M., eds., Asma bronquial, mecanismos, terapéutica., 1985, 127-151.
[46.]
L.T. Wiliams, R.J. Lefkowitz, A.M. Watanabe, D.R. Hathaway, H.R. Besch Jr..
Thyroid hormone regulation of beta adrenergic receptor number.
J Biol Chem, 252 (1977), pp. 2.787-2.789
[47.]
R.S. Williams, R.J. Lefkowitz.
Thyroid hormone regulation of alpha adrenergic receptors: studies in rat myocardium.
J Cardiovasc Pharmacol, 1 (1979), pp. 181-189
[48.]
L.T. Williams, R.J. Lefkowitz.
Regulation of rabbit myometrial alpha adrenergic receptors by estrogen and progesterone.
J Clin Invest, 60 (1977), pp. 815-818
[49.]
A. Baisset, P. Montastruc, M.A. Tran.
Influence des variations du pH sanguin sur les effets bronchodilatateurs de divers sympathomimetiques.
Rev Fr Mal Resp, 5 (1977), pp. 311
[50.]
A.J. Brugger.
Estimulantes y bloqueadores beta.
Neurotransmisores,
[51.]
J.L. Diez Jarilla, F.J. Laso Guzman, J.J. Cruz Hernández, A. Sánchez Rodríguez.
Aspects actuels dans la thérapie avec betastimulants.
Schweitz Rundschau Med (Praxis), 70 (1981), pp. 343-351
[52.]
A.S. Elguindi, R.C. Kolbeck, J.E. Carrier, W.A. Speir.
Influence of pH of bronchodilatador response to beta-agonists: in vitro studies with isoproterenol.
Am Rev Respir Dis, 119 (1979), pp. 109
[53.]
S.P. Banerjee, V.K. Sharma, J.M. Khanna.
Alterations in beta adrenergic receptor binding during ethanol withdrawal.
Nature, 276 (1978), pp. 407
[54.]
K. Yoshikawa, K. Adachi, K.M. Halprin.
On the lack of response to catecholamine stimulation by adenilate cyclase System in psoriatic lesion.
Br J Dermatol, 92 (1975), pp. 619
[55.]
P. Polgar, J.C. Vera, A.M. Rutenburg.
An altered response to cyclic AMP stimulatíng hormone in intact human leucemic lymphocytes.
Proc Soc Exp Bio Med, 154 (1977), pp. 493
[56.]
W.W. Busse, T. Lee.
Decreased adrenergic responses in lymphocytes and granulocytes in atopic eczema.
J Allergy Clin Inmunol, 58 (1976), pp. 586
[57.]
R.K. Sharma, P.K. Jeffery.
Airway beta-adrenoceptor number in cystic fibrosis and asthma.
Clin Sci, 78 (1990), pp. 409-417
[58.]
R. Ebstein, R. Belmaker, L. Grunhaus, R. Rimon.
Lithium inhibition of adrenaline-stimulated adenylate cyclase in humans.
Nature, 259 (1976), pp. 411
[59.]
D.E. Snider, C.W. Parker.
Aspirin effects of lymphocyte cyclic AMP levels in normal human subjects.
J Clin Invest, 58 (1976), pp. 524-527
[60.]
R.J. Davies, B.T. Butcher, C.E. O’Neil, J.E. Salvaggio.
In vitro studies on the inhibitory action of toluene disocianate on lymphocyte cyclic adenosine monophosphate production by isoproterenol, prostaglandin and histamine.
Am Rev Respir Dis, 115 (1977), pp. 209
[61.]
D.D. Schocken, G.S. Roth.
Reduced beta adrenergic receptor concentrations in aging man.
Nature, 267 (1977), pp. 856-858
[62.]
R. Landman, H. Bittiger, F.R. Bühler.
High affinity beta-2 adrenergic receptors in moonuclear leukocytes: similar density in young and old normal subjects.
Life Sci, 29 (1981), pp. 1.761-1.771
[63.]
D. Reinhardt, T. Zehmisch, B. Becker, M. Nagel-Hiemke.
Agedependency of alpha and beta adrenoceptors on trombocytes and lymphocytes of asthmatic and non asthmatic children.
Eur J Pediatr, 142 (1984), pp. 111-116
[64.]
S. Titinchi, M. Al Shamma, K.R. Patel, J.W. Kerr, B. Clark.
Circadian variation in number and affinity of beta-2 adrenoceptors in lymphocytes of asthmatics patients.
Clin Sci, 66 (1984), pp. 323-328
[65.]
P.J. Barnes, G.A. Fitzgerald, C.T. Dollery.
Circadian variation in adrenergic responses in asthmatic subjects.
Clin Sci, 62 (1982), pp. 349-354
[67.]
O.E. Brodde, A.E. Daul, X.L. Wang, M.C. Machel, S.P. Galant.
Dynamic exercise induced increase in lymphocyte beta-2 adrenoceptors. Abnormality in essential hypertension and its correction by antihypertensives.
Clin Pharmacol Ther, 41 (1987), pp. 371-379
[68.]
X. Parcerisa, A. Cases, M. Ingelmo, L. Revert, F. Rivera.
Aumento del número e incremento exagerado al ejercicio de los receptores beta-2 adrenérgicos linfocitarios en la hipertensión arterial moderada.
Med Clin, 91 (1988), pp. 570-572
[69.]
W. Krawietz, E.M. Klein, C. Unterberg, M. Ackenheil.
Physical activity decreases the number of beta adrenergic receptors on human 1-lymphocytes.
Klin Wochenschr, 62 (1985), pp. 73-78
[70.]
J. Butler, J.G. Kelly, K. O’Malley, F. Pidgeon.
Beta-adrenergic adaptation to acute exercise.
J Physiol, 344 (1983), pp. 1.131-1.133
[71.]
O.E. Brodde, A. Daul, N. O’Hara.
Beta adrenoceptor changes in human lymphocytes induced by dynamic exercise.
Naunyn Schmiedeberga Arch Pharmacol, 325 (1984), pp. 190-192
[72.]
K.D. Berman, E.W. Ferguson, Y.Y. Djuh, L. Wartofsky, K. Lathoom.
Beta receptors in peripheral mononuclear cells increase acutely during exercise.
Acta Endocrinol Copenh, 109 (1985), pp. 563-566
[73.]
J. Butler, M. O’Brien, K. O’Malley, J.G. Kelley.
Relationship of beta-adrenoreceptor density to fitness in atletes.
Nature, 298 (1982), pp. 609-611
[74.]
R.D. Feldman, L.E. Limbird, J. Nadeau, G.A. Fitzgerald, D. Robertson, A.J.J. Wood.
Dynamic regulation of leukocyte betaadrenergic receptor-agonist interactions by physiological changes in circulating catecholamines.
J Clin Invest, 72 (1983), pp. 164-170
[75.]
P.E. Cryer.
Physiology and pathophysiology of the human sympathoadrenal neuroendocrine system.
N Engl J Med, 303 (1980), pp. 436-444
[76.]
H. Galbo, J.J. Holst, N.J. Christensen, J. Hilsted.
Glucagon and plasma catecholamines during beta-receptor blockade in exercising man.
J Appl Physiol, 40 (1976), pp. 855-863
[77.]
M.J. Frey, D. Mancini, D. Fischberg, J.R. Wilson, P.B. Molinoff.
Effect of exercise duration on density and coupling of beta adrenergic receptors on human mononuclear cells.
J Appl Physiol, 66 (1989), pp. 1.494-1.500
[78.]
A.J. Edwards, T.H. Bacon, C.A. Elms, R. Veradi, M. Felder, S.C. Knight.
Changes in the populations of limphoid cells in human peripheral blood following physical exercise.
Clin Exp Immunol, 58 (1984), pp. 420-427
[79.]
E. Soppi, P. Vario, J. Eskola, L.A. Laitmen.
Effect of estrenuous physical stress on circulating lymphocyte number and function before and after training.
J Clin Lab Immunol, 8 (1982), pp. 43-46
[80.]
N.H. Bishopric, H.J. Cohen, R.J. Lefeldmankowitz.
Beta adrenergic receptors is lymphocyte subpopulations.
J Allergy Clin Immunol, 65 (1980), pp. 29-33
[81.]
M.M. Kahn, P. Sansoni, E.E. Silverman, E.G. Engelman, K.L. Melmon.
Beta adrenergic receptors on human supressor, helper, and cytotoxic lymphocytes.
Biochem Pharmacol, 35 (1986), pp. 1.137-1.142
[83.]
L. Fitzgerald.
Exercise and immune System.
Immunology Today, 9 (1988), pp. 337-339
[84.]
F.P. Nijkamp, P.A.J. Henricks.
Receptors in airway disease. Betaadrenoceptors in lung inflammation.
Am Rev Respir Dis, 14L (1990), pp. S145-S150
[85.]
H.R. Bourne, L.M. Lichtenstein, K.L. Melmon, C.S. Henney, Y. Weinstein, G.M. Shearer.
Modulation of inflammation and immunity by cAMP: receptors for vasoactive hormones and mediadors of inflammation regulate many leukocyte functions.
Science, 184 (1974), pp. 19-28
[86.]
R.D. Feldman, G.W. Hunninghake, W.L. McArdle.
Beta adrenergic receptor-mediated supression of interluekin 2 receptors in human lymphocytes.
J Immunol, 139 (1987), pp. 3.355-3.359
[87.]
I. Paegelow, H. Werner.
Influence of adrenergic agonist and antagonist on lymphokine secretion in vitro.
Int J Immunopharmacol, 9 (1987), pp. 761-768
[88.]
S.K. Beckner, W.L. Farrar.
Inhibition of adenyl cyclase by IL 2 in human T lymphocytes is mediated by protein kinase C.
Biochem Biophys Res Commun, 145 (1987), pp. 176-182
[89.]
V.L. Davis, H.S. Earp, D.A. Stempel.
Interferon inhibits agonistinduced cyclic AMP accumulation in human lymphocytes.
Am Rev Respir Dis, 130 (1984), pp. 167-170
[90.]
R.M. Friedman.
Cell surface alterations induced by interferon.
Methods Enzymol, 79 (1981), pp. 458-461
[91.]
R.M.A. Landmann, F.B. Müller, C. Perini, P. Wesp, P. Erne, F.R. Bühler.
Changes of immunoregulatory cells induced by psychological and physical stress: relationship to plasma catecholamines.
Clin Exp Immunol, 58 (1984), pp. 127-135
[92.]
B. Ahlborg, G. Ahlborg.
Exercise leukocytosis with and without beta adrenergic blockade.
Acta Med Scand, 187 (1970), pp. 241-246
[93.]
A.S. Maisel, K.U. Knowlton, P. Fowler, et al.
Adrenergic control of circulating lymphocyte subpopulations. Effects of congestive. heart failure, dynamic exercise andterbutaline treatment.
J Clin Invest, 85 (1990), pp. 462-467
[94.]
D.V. Cookson, C.E. Reed.
A comparison of the effects of isoproterenol in normal and asthmatic subjects.
Am Rev Respir Dis, 88 (1963), pp. 636-643
[95.]
S.D. Lockey, J.A. Glennon, C.E. Reed.
Comparison of some metabolic responses in normal and asthmatic subjeets to epinephrine and glucagon.
J Allergy, 40 (1967), pp. 349-354
[96.]
S. Makino, J.J. Quellete, C.E. Reed, C. Fishel.
Correlation between increased bronchial response to acetyl choline and diminished metabolic and eosinopenic responses to epinephrine in asthma.
J Allergy, 46 (1970), pp. 178-189
[97.]
C.W. Parker, J.W. Smith.
Alterations in cyclic adenosine monophosphate metabolism in human bronchial asthma.
J Clin Invest, 52 (1973), pp. 48-59
[98.]
R.A. Bernstein, L. Linarelli, M.A. Faktor, G.A. Friday, A.L. Drash, P.J. Fireman.
Decreased urinary 3’5’ adenosine monophosphate (cyclic AMP) in asthmatics.
J Lab Clin Med, 80 (1972), pp. 772-779
[99.]
K. Kariman.
Beta adrenergic receptor binding in lymphocytes from patients with asthma.
Lung, 158 (1980), pp. 41-51
[100.]
S.M. Brooks, K. McGowan, P. Altenau.
Relationship between beta adrenergic binding in lymphocyte and severity of disease in asthma.
Chest, 75 (1979), pp. 232-233
[101.]
S.M. Brooks, K. McGowan, I.L. Bernstein, P. Altenau, J. Peagler.
Relationship between number of beta adrenergic receptors in lymphocytes and disease severity in asthma.
J Allergy Clin Immunol, 63 (1979), pp. 401-406
[102.]
I. Bittera, K. Gyurkovits, G. Falkay, E. Eck, M. Koltai.
Beta adrenergic receptors of lymphocytes in children with allergic respiratory diseases.
Pediatr Pulmonol, 5 (1988), pp. 69-73
[103.]
G.H. Koeter, H. Meurs, J. Kraan, et al.
The beta-adrenergic receptor and bronchial hyperreactivity.
Bull Eur Physiopathol Respir, 22 (1986), pp. 148-152
[104.]
S. Motojima, T. Yukuda, T. Fukuda, S. Makino.
Changes in airway responsiveness and beta and alpha-1 adrenergic receptors in the lung of guinea pigs with experimental asthma.
Allergy, 44 (1989), pp. 66-74
[105.]
K. Larsson, P. Hjemdahl, E. Theodorsson.
Acute bronchoconstriction is not a stimulus for sympatho-adrenal activation in asthmatic or healthy subjeets.
Eur Respir J, 3 (1990), pp. 273-281
[106.]
P.J. Barnes.
Airway inflammation and autonomic control.
Eur J Respir Dis, 69 (1986), pp. 80-87
[107.]
P.W. Ind, P.J. Barnes, S.R. Durham, A.B. Kay.
Propanololinduced bronchoconstriction in asthma: beta receptor blockade and mediado1release.
Am Rev Respir Dis, 129 (1984), pp. A10
[108.]
P.W. Ind, R.C. Causon, M.J. Brown, P.J. Barnes.
Circulating catecholamines in acute asthma.
Br Med J, 290 (1985), pp. 267-279
[109.]
M.E. Conolly, J.K. Greenacre.
The lymphocyte beta-adrenoceptor in normal subjeets and patients with bronchial asthma.
J Clin Invest, 58 (1976), pp. 1.307-1.316
[110.]
D.P. Tashkin, M.E. Conolly, R.I. Deutsch, et al.
Subsentivization of beta-adrenoceptors in airways and lymphocytes of healthy and asthmatic subjeets.
Am Rev Respir Dis, 125 (1982), pp. 185-193
[111.]
S.P. Galant, L. Duriseti, S. Underwood, S. Allred, P.A. Insel.
Beta adrenergic receptors of polymorphonuclear particulates in bronchial asthma.
J Clin Invest, 65 (1980), pp. 577-585
[112.]
S.P. Galant, L. Duriseti, S. Underwood, P.A. Insel.
Decreased beta adrenergic receptors on polymorphonuclear leukocytes after adrenergic therapy.
N Engl J Med, 299 (1978), pp. 933-936
[113.]
Y. Sano, G. Watt, R.G. Townley.
Decreased mononuclear cell betaadrenergic receptors in bronchial asthma: parallel studies of lymphocyte and granulocyte desensitization.
J Allergy Clin Immunol, 72 (1983), pp. 495-503
[114.]
O.E. Brodde, M. Brinksmann, R. Schmuth, N. O’Hara, A. Daul.
Terbutaline-induced desensitization of human lymphocyte beta-2 adrenoceptors.
J Clin Invest, 76 (1985), pp. 1.096-1.101
[115.]
S. Makino, K. Ikemori, T. Kashima, T. Fukuda.
Comparison of cylic adenosine monophosphate response of lymphocytes in normal and asthmatic subjects to norepinephrine and salbutamol.
J Allergy Clin Immunol, 59 (1977), pp. 348-352
[116.]
S. Makino, R. Ikemori, T. Fukuda, S. Motojima.
Relationship between responsiveness of the bronchi to acetylcholine and cyclic AMP response of lymphocytes to beta-1 and beta-2 adrenergic receptor stimulation in patients with asthma.
Allergy, 38 (1983), pp. 37-42
[117.]
S. Motokima, T. Fukuda, S. Makino.
Measurement of beta adrenergic receptors on lymphocytes in normal subjeets and asthmatics in relation to beta adrenergic hyperglycaemic response and bronchial responsiveness.
Allergy, 38 (1983), pp. 331-337
[118.]
H. Meurs, G.H. Koeter, K. De Vries, H.F. Kauffman.
Dynamics of the lymphocyte beta-adrenoceptor system in patients with allergic bronchial asthma.
Eur J Respir Dis, (1984), pp. 47-61
[119.]
H. Meurs, H.F. Kauffman, G.H. Koeter, A. Timmermans, K. De Vries.
Regulation of the beta-receptor-adenylate cyclase system in lymphocytes of allergic patients with asthma: possible role for protein kinase C in allergen-induced nonspecific refractoriness of adenylate cyclase.
J Allergy Clin Immunol, 80 (1987), pp. 326-329
[120.]
C.J. Van Koppen, J.F. Rodrigues de Miranda, A.J. Beld, C.L.A. Van Herwaarden, J-.W.J. Lammers, C.A.M. Van Ginneken.
Betaadrenoceptor binding and induced relaxation in airway smooth muscle from patients with chronic airflow obstruction.
Thorax, 44 (1989), pp. 28-35
[121.]
F. Taki, K. Takagi, T. Satake, S. Sugiyama, T. Ozawa.
The role of phospholipase in reduced beta adrenergic responsiveness in experimental asthma.
Am Rev Respir Dis, 133 (1986), pp. 362-366
[122.]
J.L. Diez Jarilla, M. Damon, P. Godard, F.B. Michel.
Liberación de radicales libres del oxígeno por los macrófagos alveolares de los pacientes asmáticos.
Arch Bronconeumol, 22 (1986), pp. 144-145
[123.]
J.C. Venter, C.M. Fraser, L.C. Harrinson.
Autoantibodies to beta-2 adrenergic receptors: a possible cause of adrenergic hyporresponsiveness in allergic rhinitis and asthma.
Science, 207 (1980), pp. 1.361-1.363
[124.]
C.M. Fraser, J.C. Venter, M. Kaliner.
Autonomic abnormalities and autoantibodies to beta-adrenergic receptors.
N Engl J Med, 305 (1981), pp. 1.165-1.170
[125.]
M. Kalimer, J. Shelhamer, P.B. Davis, L.J. Smith, J.C. Venter.
Autonomic nervous system abnormalities and allergy.
Ann Int Med, 96 (1982), pp. 349-357
[126.]
C.J. Corrigan, A. Hartnell, A.B. Kay.
T lymphocyte activation in acute severe asthma.
Lancet, 1 (1988), pp. 1.129-1.131
[127.]
C.J. Corrigan, A.B. Kay.
CD4 t-lymphocyte activation in acute severe asthma. Relationship to disease severity and atopic status.
Am Rev Respir Dis, 141 (1990), pp. 970-977
[128.]
M.C. González, P. Díaz, F.R. Galleguillos, P. Ancic, O. Cromwell, A.B. Kay.
Allergen-induced recruitment of bronchoalveolar helper (OKT4) and suppressor (OKT8) T-cells in asthma.
Am Rev Respir Dis, 136 (1987), pp. 600-604
[129.]
J. Kus.
Lymphocyte activation by house dust allergen in asthma: analysis with monoclonal antibodies.
Clin Exp Allergy, 20 (1990), pp. 165-170
[130.]
A.A. Gerblich, A.E. Campell, M.R. Schuyler.
Changes in T-lymphocyte subpopulations after antigenic bronchial provocation in asthmatics.
N Engl J Med, 310 (1984), pp. 1.349-1.352
[131.]
C.Y. Lin, Y.C. Kuo, W.T. Liu, C.C. Lin.
Immunomodulation of influenza virus infection in the precipitating asthma attack.
Chest, 6 (1988), pp. 1.234-1.238
[132.]
D. Körholz, K. Seeger, M. Griese, V. Wahn, A. Reifenhäuser, D. Reinhardt.
Beta-adrenoceptor density and resolution of high and low affinity State on B and T cells in asthmatic and non asthmatic children.
Eur J Pediatr, 147 (1988), pp. 116-120
[133.]
E. Huszar, I. Herjavecz, L.A. Debreczeni.
The beta-adrenoceptors of lymphocytes in asthmatic patients treated with beta-agonists.
Bull Eur Physiopathol Respir, 23 (1987), pp. 115s-117s
[134.]
N.L.V. Svedmyr, S.A. Larsson, G.K. Thiringer.
Development of «resistance» in beta-adrenergic receptors of asthmatic patients.
Chest, 69 (1976), pp. 479-483
[135.]
J.L. Díez Jarilla, B. Fernández Gutiérrez, G. Ocio Achaerandio, M.A. Montoliu Sanclement, C. Rodríguez Menéndez.
Effect of methacholine bronchial provocation on plasma catecholamines and. lymphocyte beta adrenergic receptors in stable asthmatics.
Eur Respir J, 4 (1991), pp. 459s
[136.]
A. Martinsson, K. Larsson, P. Hjemdahl.
Reduced beta-2 adrenoceptor responsiveness in exercise-induced asthma.
Chest, 88 (1985), pp. 594-600
[137.]
C. Chryssanthopoulos, J.J. Barboriak, J.N. Finck.
Adrenergic responses of asthmatic and normal subjects to submaximal and maximal workloads.
J Allergy Clin Immunol, 61 (1978), pp. 17-22
[138.]
J. Zielinski, E. Chodowska, A. Radomyski, Z. Araskiewicz, S. Kozlowski.
Plasma catecholamines during exercise-induced bronchoconstriction in bronchial asthma.
Thorax, 35 (1980), pp. 823-827
[139.]
I.A. Gilbert, K.A. Lenner, E.R. McFadden Jr..
Sympathoadrenal response to repetitive exercise in normal and asthmatic subjects.
J Appl Physiol, 64 (1988), pp. 2.667-2.674
[140.]
P.J. Barnes, M.J. Brown, M. Silverman, C.T. Dorelly.
Circulating catecholamines in exercise and hyperventilation-induced asthma.
Thorax, 36 (1981), pp. 435-440
[141.]
J. Griffiths, F.Y. Leung, S. Grzybowski, M.W. Morin, M.B. ChangYeung.
Sequential stimation of plasma catecholamines in exercise-induced asthma.
Chest, 62 (1972), pp. 257-533
[142.]
K. Larsson, P. Hjemdahl, A. Martinsson.
Symphatoadrenal reactivity in exercise-induced asthma.
Chest, 82 (1982), pp. 560-567
[143.]
J.B. Warren, N. Dalton, C. Turner, P. Toseland.
Adrenaline secretion during exercise.
Clin Sci, 66 (1984), pp. 87-90
[144.]
J.L. Díez Jarilla, J.J. Cruz Hernández, J. Del Pozo Montes, F. Sanchez Gascón, J. De Portugal Alvarez.
Corticoides y agonistas beta-2 selectivos: sinergismo espirométrico y antagonismo oximétrico.
Rev Clin Esp, 167 (1982), pp. 113-116
[145.]
K.K. Hui, J.L. Yu.
Ketotifen increases cyclic adenosine 3’5’monophosphate in intact human lymphocyte and potentiates other adenylate cyclase activating agents.
Life Sci, 40 (1987), pp. 1.259-1.265
[146.]
H.S. Nelson, S.J. Szefler, R.J. Martin.
Regular inhaled betaadrenergic agonists in the treatment of bronchial asthma: beneficial or detrimental?.
Am Rev Respir Dis, 144 (1991), pp. 149-150
[147.]
J. Rees.
Beta-2 agonists and asthma.
Br Med J, 302 (1991), pp. 1.166-1.167
[148.]
J. Kraan, G.H. Koeter, T.W. Mark, H.J. Sluiter, K. De Vries.
Changes in bronchial hyperreactivity induced by 2 weeks treatment with antiasthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline.
J Allergy Clin Immunol, 76 (1985), pp. 628-636
[149.]
A.S. Vathanen, A.J. Knox, B.G. Higgins, J.R. Britton, A.E. Tattersfield.
Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline.
Lancet, (1988), pp. 554-558
[150.]
N.R. Sears, D.R. Taylor, C.G. Print, et al.
Regular inhaled betaagonist treatment in bronchial asthma.
lancet, 33 (1990), pp. 1.391-1.396
[151.]
British Thoracic Society Research Unit of the Royal College of Physicians of London, King's Fund.
Centre. National Asthma Campaign. Guidelines for the management of asthma in adults. I. Chronic persistent asthma.
Br Med J, 301 (1990), pp. 651-653
[152.]
B. Richter.
Asthma and regular beta agonist treatment.
Br Med J, 303 (1991), pp. 648
[153.]
J.C. Mitohoefer, W.F. Porter, M.S. Karetzky.
Indications for the use of sodium bicarbonate in the treatment of intractable asthma.
Respiration, 25 (1968), pp. 201
[154.]
J.L. Díez Jarilla, J. González Maclas, F.J. Laso Guzman, S. De Castro Del Pozo.
Beta-blockade in asthma.
Br Med J, 283 (1981), pp. 309
Copyright © 1992. Sociedad Española de Neumología y Cirugía Torácica
